Who owns Xbiotech?
- Ticker: XBIT
- CUSIP Number: 98400h102
Tip: Access positions for across all investors
Analyze quarterly positions in Xbiotech with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Xbiotech stock
Who bought or sold Xbiotech this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| BlackRock | 321k | $739k | 10% | Jun 2026 |
|
| Geode Capital Management | 214k | $493k | -7% | Jun 2026 |
|
| Vanguard Capital Management | 200k | $460k | 0% | Jun 2026 |
|
| Rbf Capital | 199k | $457k | 0% | Jun 2026 |
|
| Morgan Stanley | 166k | $389k | 1% | Mar 2026 |
|
| Bridgeway Capital Management | 98k | $226k | 0% | Jun 2026 |
|
| Vanguard Fiduciary Trust | 92k | $212k | 1% | Jun 2026 |
|
| Jane Street | 86k | $198k | 43% | Jun 2026 |
|
| Millennium Management | 79k | $183k | -25% | Jun 2026 |
|
| Susquehanna International | 74k | $170k | 250% | Jun 2026 |
|
| State Street Corporation | 73k | $172k | 0% | Mar 2026 |
|
| Northern Trust | 66k | $152k | -13% | Jun 2026 |
|
| Empowered Funds | 60k | $137k | 0% | Jun 2026 |
|
| Renaissance Technologies | 42k | $96k | 86% | Jun 2026 |
|
| Bank of New York Mellon | 39k | $91k | 0% | Jun 2026 |
|
| Dimensional Fund Advisors | 36k | $83k | 0% | Jun 2026 |
|
| Squarepoint Ops | 35k | $80k | -16% | Jun 2026 |
|
| Qube Research & Technologies | 34k | $77k | 80% | Jun 2026 |
|
| GSA Capital Partners | 31k | $71k | 100% | Jun 2026 |
|
| Citadel Advisors | 29k | $67k | 100% | Jun 2026 |
|
| Connor, Clark & Lunn Investment Management | 28k | $64k | -3% | Jun 2026 |
|
| Bnp Paribas Arbitrage, Snc | 27k | $61k | -3% | Jun 2026 |
|
| National Bank Of Canada /fi/ | 25k | $58k | 0% | Jun 2026 |
|
| Bank of America Corporation | 24k | $55k | -35% | Jun 2026 |
|
| American Century Companies | 18k | $42k | -3% | Jun 2026 |
|
| TNB Financial | 13k | $31k | 0% | Jun 2026 |
|
| XTX Topco | 13k | $30k | -27% | Jun 2026 |
|
| Pinnacle Financial Partners | 12k | $27k | 0% | Jun 2026 |
|
| Vanguard Global Advisers | 7.0k | $16k | 0% | Jun 2026 |
|
| UBS Group | 5.0k | $12k | 0% | Jun 2026 |
|
| Royal Bank of Canada | 1.2k | $0 | 1% | Jun 2026 |
|
| McIlrath & Eck | 753.00 | $1.8k | 0% | Mar 2026 |
|
| Jones Financial Companies, L.L | 370.00 | $861.989000 | 0% | Jun 2026 |
|
| Jpmorgan Chase & Co | 96.00 | $223.996800 | 100% | Jun 2026 |
|
| Barclays | 94.00 | $216.002600 | 100% | Jun 2026 |
|
| SBI Securities | 37.00 | $85.000100 | 0% | Jun 2026 |
|
| Larson Financial Group | 21.00 | $47.999700 | 0% | Jun 2026 |
|
| CWM | 13.00 | $30.999800 | -43% | Mar 2026 |
|
| Caitong International Asset Management | 11.00 | $24.999700 | 0% | Jun 2026 |
|
Who sold out of Xbiotech?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Rhumbline Advisers | Mar 2026 | 928.00 | $2.2k |
| SRS Capital Advisors | Mar 2026 | 15.00 | $34.999500 |